Homepage

The aim of the Company is to develop, manufacture and distribute high quality and effective therapeutic products (medicines, food supplements and medical devices) that are accessible to all, to prolong life and improve the quality of life.  

Wellbeing, Innovation, and Sustainable Health Solutions

At Goodwill Pharma, wellbeing is not a slogan—it is the measurable outcome we work for every day. We develop, manufacture, and distribute pharmaceuticals and dietary supplements designed to improve quality of life, with particular focus on challenges driven by ageing and environmental stressors. Our portfolio supports people facing age-related decline, chronic conditions that emerge over time, and a wide range of acquired diseases that impact long-term health, resilience, and everyday functionality.

What differentiates Goodwill Pharma is our commitment to complete therapeutic solutions. For each key disease or symptom group, we aim to deliver an integrated approach—combining prescription medicines and scientifically grounded food supplements into a coherent, end-to-end solution. This strategy reflects real patient needs, where effective care often requires more than a single product category.

Our product development philosophy is rooted in medical science and holistic thinking, executed with pharmaceutical-grade precision. We unite evidence-based medicine with a broader understanding of human physiology, prevention, and long-term wellbeing—ensuring that every formulation meets the highest standards of efficacy, safety, and consistency.

Sustainability is a core strategic pillar of Goodwill Pharma. We are committed to responsible innovation, efficient manufacturing, and long-term value creation with reduced environmental impact. We believe that sustainable operations are essential not only for society, but also for building resilient, future-proof healthcare businesses.

Innovation drives our growth. Goodwill Pharma operates a continuous development and launch model, with new products entering the market on a regular—often monthly—basis. This disciplined innovation pipeline supports our objective of long-term corporate growth and sustained share value appreciation, firmly anchored in real products, real markets, and measurable performance.

In parallel, we are actively seeking pharmaceutical in-licensing and out-licensing opportunities, with a strategic focus on Central and Eastern Europe, while remaining open to broader regional collaborations. We also pursue distribution partnerships to expand market access for licensed pharmaceutical products.

For our food supplement portfolio, we are looking for global distributor and private-label partners, as well as financial and strategic partners, to support worldwide market entry, scaling, and brand building. Our goal is to establish strong, mutually beneficial partnerships that enable rapid and sustainable international expansion.

All of this is delivered in full alignment with the highest pharmaceutical quality and regulatory standards—from development and manufacturing to quality assurance and distribution. Our long-term ambition is clear: to build a trusted global presence in healthcare, defined by innovation, sustainability, medical credibility, and enduring value for patients, partners, and shareholders alike.